Bar-Ilan University's Gonda (Goldschmied) Multidisciplinary Brain Research Center was recently awarded a €3.6 million Erasmus Mundus Joint Master’s (EMJM) grant for a groundbreaking Brain and Data Science graduate program, the first time an Israeli university has won this prestigious grant.

For the first time, academic scholars in vision science from around the country came together for an international conference organized by the Israel Vision Science Society and the School of Optometry and Vision Science at Bar-Ilan University. They conference highlighted the finest research taking place today in the field.

Research conducted at Bar-Ilan University’s Gonda Multidisciplinary Brain Research Center shows that stem cells originating in the placenta can reach damaged tissue in the brains of drug addicts and initiate a rehabilitation process.

Research conducted by Prof. Doron Avraham, from the Department of General History at Bar-Ilan University, focuses on German Zionists, Orthodox and liberal Jews, as well as those of other political orientations, during the period of German colonialism, in the years 1884-1919. 

Meet Ori Ernst, a PhD candidate at the Natural Language Processing Lab at Bar-Ilan University's Department of Computer Science, whose research focuses on multi-document summarization and semantic relations between texts.

To mark World Alzheimer's Day on September 21, Prof. Eitan Okun, of the Multidisciplinary Brain Research Center at Bar-Ilan University, writes about his work at the Paul Feder Laboratory for Alzheimer's Disease Research that aims to treat the phenomenon of early Alzheimer's in people with Down syndrome.

Prolonged exposure to extensive information and data from the media during the COVID-19 pandemic led many Israeli citizens to experience information overload, along with overwhelming anxiety and fatigue. A study conducted at Bar-Ilan University’s Department of Information Science finds that it is possible to prevent “media fatigue” if steps are taken to disseminate clear digital information in real time to the public at large.

Being vaccinated with at least two doses of Pfizer vaccines dramatically reduces most of the long-term symptoms individuals reported months after contracting COVID-19, a new study shows.

In this study, eight of the ten most-commonly reported symptoms were reported between 50 and 80% less often among individuals who received at least two doses of COVID-19 vaccine compared with those who received no doses.